HNGE
Hinge Health, Inc.HNGE
HNGE
About: Hinge Health Inc is a technology platform for individuals seeking to treat and prevent joint and muscle pain. Through a combination of AI-powered motion tracking technology, the Company's platform helps members address musculoskeletal (MSK) conditions, enables improved member outcomes and supports cost reductions for its clients. The Company's clients are self-insured employers.
–
Funds holding %
of 7,312 funds
0
Analysts bullish %
of 11 analysts
Fund manager confidence
Research analyst outlook
11 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$41
14%
downside
Avg. target
$46
4%
downside
High target
$52
9%
upside
11 analyst ratings
11 positive
100%
0 neutral
0%
0 negative
0%
Stifel David Grossman | 1%upside $48 | Buy Initiated | 16 Jun 2025 |
Truist Securities Jailendra Singh | 1%upside $48 | Buy Initiated | 16 Jun 2025 |
Raymond James Brian Peterson | 6%downside $45 | Outperform Initiated | 16 Jun 2025 |
Piper Sandler Jessica Tassan | 14%downside $41 | Overweight Initiated | 16 Jun 2025 |
Morgan Stanley Craig Hettenbach | 3%downside $46 | Overweight Initiated | 16 Jun 2025 |
Financial journalist opinion
Based on 6 articles about HNGE published over the past 30 days
Neutral
Business Wire
3 days ago
Hinge Health to announce second quarter 2025 financial results on August 5, 2025
SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) announced today that it will report its financial results for the quarterly period ended June 30, 2025, after the close of the market on Tuesday, August 5, 2025. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relations webs.
Positive
Investors Business Daily
1 week ago
Microsoft, Meta And 3 IPOs Lead This Barrage Of Breakout Stocks To Watch
As the market uptrend continues, Microsoft, Meta and more continue power this impressive lineup of 81 stocks to watch.
Positive
Investors Business Daily
2 weeks ago
IPO Leader Hinge Stock Is Breaking Out Past Its First Buy Point
IPO Leader Hinge stock is breaking out past its first buy point, as the S&P 500 and Nasdaq set record highs.
Positive
Investors Business Daily
2 weeks ago
Stock Of The Day Trips Buy Point As IPO's Growth Booms
Hinge Health says the number of patients it helps jumped 43% at the end of 2024 from the year-ago period.
Neutral
Business Wire
3 weeks ago
Hinge Health Announces HingeSelect - a High-performance Network Delivering Unified Musculoskeletal Care
SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE:HNGE), today announced the launch of HingeSelect, a high-performance provider network for musculoskeletal (MSK) care. Hinge Health's technology and in-house orthopedic physicians triage and direct downstream care, prioritizing the most appropriate evidence-based treatment. When in-person care, such as imaging or injections is required, members are seamlessly connected to pre-vetted providers at up to 50% below PPO rates. Combined with Hin.
Positive
Benzinga
3 weeks ago
Hinge Health's Tech Is Primed To Capture America's Untapped MSK Pain Market: Analyst
In May, Hinge Health Inc HNGE priced its initial public offering of 13.7 million shares at $32 per share.
Neutral
Business Wire
1 month ago
Fully insured medical claims analysis shows significant cost savings and 2.4x ROI for Hinge Health populations
SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced results from a medical claims analysis revealing an average $2,343 savings per member per year on care for chronic musculoskeletal (MSK) conditions and a 2.4x return on investment (ROI) for fully insured health plan members using its digital MSK platform. The methodology of the medical claims analysis of 4,788 health plan members was validated by Gallagher, a leading global insurance brokerage, risk management, and.
Positive
Investors Business Daily
1 month ago
IPO Stock Of The Week: Hinge Health Eyes First Buy Point
IPO Stock Of The Week: Health care leader Hinge Health is approaching its first buy point after its debut in recent week.
Neutral
Seeking Alpha
1 month ago
IPO Filings Remain Low In Q2
IPO activity remains low in early 2025 despite recent high-profile debuts and filings. May 2025 saw the lowest number of IPO filings in six months, continuing a slow trend. Optimism for a stronger IPO market in the second half of the year hinges on market stability and potential interest rate cuts.
Positive
Seeking Alpha
1 month ago
Hinge Health: Why Digital Physiotherapy Could Outrun The Competition
Hinge Health is a digital physiotherapy leader with strong technology. Outcomes data shows that 68% pain reduction for patients, and 2.4x ROI for employers. Hinge's competitive edge is the largest dataset, no need for sensors, and integrated pain management. My base case DCF model values HNGE at $43/share (1-year) and $60-$80/share (5-years), with upside from Medicare/Medicaid and international expansion.
Charts implemented using Lightweight Charts™